Evogene EVGN Q4 2025 Earnings Miss EPS 061 vs 027 Expected Biotech ETFs Attract Investor Focus as Sector Dynamics Shift Apollo Tyres Strong Quarter Overshadowed by Rising Input Cost Pressures General GM Q1 2026 Beat Revenue NA EPS Exceeds by Significant Redwood Trust Senior Notes RWTN Inch Higher Yield Attraction and Technical Support in Focus Ultra Clean Holdings UCTT Surges 426 as Bulls Test Resistance Near 8821 Twist Bioscience Surges 295 Key Levels and Potential for Further Gains Skillz Inc SKLZ Surges Over 6 Analysis of the Move and Key Levels to Watch ZLAB Zai Lab beats Q4 2025 loss estimates posts 153 percent year over year revenue gain shares rise 393 percent